Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives-Reference-Cited by-同舟云学术

Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives

Published:2012-03 Issue:3 Volume:23 Page:556-562
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sehouli J.,Alfaro V.,González-Martín A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/3/556/610181/mdr321.pdf

Reference50 articles.

1. Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer;Gadducci;Int J Gynecol Cancer,2008

2. Monk BJ. Recurrent ovarian cancer Exploring options for patients who relapse 6 to 12 months after chemotherapyOncology Biotech & News (HCP Beta Live) 2010. Priority report: 1–6

3. Management of partially platinum-sensitive relapsed ovarian cancer;Kaye;Eur J Cancer Suppl,2008

4. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials;Blackledge;Br J Cancer,1989

5. Management strategies for partially platinum-sensitive ovarian cancer;Ledermann;Am J Cancer,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?;Molecular Diagnosis & Therapy;2024-07-05

2. Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL‐6‐STAT3 signalling;Journal of Cellular and Molecular Medicine;2023-06-06

3. Successful secondary radical operation on unretractable metastatic platinum-sensitive recurrent ovarian cancer by immunotherapy: a case report;Annals of Translational Medicine;2022-06

4. Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer;Case Reports in Oncology;2019-06-13

5. Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study;International Journal of Gynecologic Cancer;2019-01